News
Pfizer (PFE) stock in focus as the company with Astellas Pharma (ALPMF) (ALPMY) announce a Phase 3 trial win for their ...
Challenged over her refusal to release her email exchange with Pfizer CEO, von der Leyen survives after 360 MEPs vote against ...
Xaira Therapeutics named Jeff Jonker as president and chief operating officer. Norstella appointed Kris Joshi as its CEO. ABS Bio added Ehab Alramahy as president and CEO. Radiant Biotherapeutics ...
Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...
European Commission President Ursula von der Leyen comfortably survived a vote of no confidence on Thursday, as an overwhelming number of European Union lawmakers rejected a censure motion against her ...
Pharmaceuticals have a very complex supply chain and a very long supply chain,” Deputy Prime Minister Gan Kim Yong said at a ...
19h
Barchart on MSNPfizer Earnings Preview: What to ExpectWith a market cap of $145.7 billion, Pfizer Inc. (PFE) is a global, research-driven biopharmaceutical company, specializing in the discovery, development, and commercialization of innovative medicines ...
On June 2, the company announced that it had agreed with Bristol Myers Squibb for the global joint development and ...
Irish-made medicines heading to the US face steep new duties, raising alarm among patients, producers and investors on both ...
The deal gives AstraZeneca’s rare disease unit Alexion access to specialized capsids developed by the Japanese biotech JCR ...
Susman shared Tuesday that she’ll be stepping down from her role as EVP and chief corporate affairs officer after 18 years with the company. Susman joined Pfizer in 2007 and helped lead the company ...
22h
Zacks Investment Research on MSNJNJ vs. Pfizer: Which Pharma Giant is the Better Investment Now?Johnson & Johnson JNJ and Pfizer PFE rank among the world’s largest pharmaceutical companies, each with broad and diversified ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results